Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Neumora_Therapeutics
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
gptkb:Bill_Martin
|
| gptkbp:focusesOn |
neurobehavioral disorders
|
| gptkbp:foundedYear |
2015
|
| gptkbp:hasProductPipeline |
BTRX-246040
BTRX-323511 BTRX-335140 |
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
BlackThorn Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
precision medicine
central nervous system disorders |
| gptkbp:technology |
data science
neuroinformatics |
| gptkbp:bfsParent |
gptkb:Neumora_Therapeutics
|
| gptkbp:bfsLayer |
7
|